Using a patient population from the randomized FAST clinical trial which studied the efficacy and safety of antimetabolites for noninfectious uveitis, investigators assessed whether these agents had an effect on patient quality of life (QoL). Source: AAO
A once-daily dose of the novel drug omidenepag isopropyl showed the same efficacy as twice-daily dosing and was more tolerable for patients. Source: AAO
Investigators evaluated the rate of SARS-CoV-2 in tears collected from patients with COVID-19 in intensive care units in Italy and the rate in healthy participants. Source: AAO
This study looked for cases of actinic granuloma in patient records covering a 6-year period to discover its clinical manifestations. Source: AAO
A 72-month randomized controlled study confirmed the long-term safety of laser iridotomy on corneal endothelium in primary angle-closure suspects. Source: AAO
This large-scale multicenter trial evaluated data from patients with moderate to severe dry eye disease for associations between risk factors and severity of DED signs and symptoms. Source: AAO